140 related articles for article (PubMed ID: 31337696)
1. Budget Impact Analysis of the Change in Peritoneal Dialysis Use Rate in Korea.
Kim J; Lee NR; Son SK; Lee JP; Park JT; Kim YJ; Ryu DR
Perit Dial Int; 2019; 39(6):547-552. PubMed ID: 31337696
[No Abstract] [Full Text] [Related]
2. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
Liu FX; Treharne C; Culleton B; Crowe L; Arici M
BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
[TBL] [Abstract][Full Text] [Related]
3. Budget Impact Analysis of Peritoneal Dialysis versus Conventional In-Center Hemodialysis in Malaysia.
Bavanandan S; Ahmad G; Teo AH; Chen L; Liu FX
Value Health Reg Issues; 2016 May; 9():8-14. PubMed ID: 27881266
[TBL] [Abstract][Full Text] [Related]
4. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
[TBL] [Abstract][Full Text] [Related]
5. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
6. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
7. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis versus peritoneal dialysis, which is cost-effective?
Atapour A; Eshaghian A; Taheri D; Dolatkhah S
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal dialysis in Asia.
Cheng IK
Perit Dial Int; 1996; 16 Suppl 1():S381-5. PubMed ID: 8728228
[TBL] [Abstract][Full Text] [Related]
10. Gaining efficiencies: resources and demand for dialysis around the globe.
Neil N; Walker DR; Sesso R; Blackburn JC; Tschosik EA; Sciaraffia V; García-Contreras F; Capsa D; Bhattacharyya SK
Value Health; 2009; 12(1):73-9. PubMed ID: 18680485
[TBL] [Abstract][Full Text] [Related]
11. Assisted Peritoneal Dialysis for Older People with End-Stage Renal Disease: The French and Danish Experience.
Béchade C; Lobbedez T; Ivarsen P; Povlsen JV
Perit Dial Int; 2015 Nov; 35(6):663-6. PubMed ID: 26702010
[TBL] [Abstract][Full Text] [Related]
12. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
14. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
[TBL] [Abstract][Full Text] [Related]
15. A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.
de Abreu MM; Walker DR; Sesso RC; Ferraz MB
Perit Dial Int; 2013; 33(3):304-15. PubMed ID: 23209041
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?
Yousefi M; Rezaei S; Hajebrahimi S; Falsafi N; Keshvari-Shad F
BMC Nephrol; 2024 Mar; 25(1):85. PubMed ID: 38448887
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective.
Treharne C; Liu FX; Arici M; Crowe L; Farooqui U
Appl Health Econ Health Policy; 2014 Aug; 12(4):409-20. PubMed ID: 25017433
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time.
Weijnen TJ; van Hamersvelt HW; Just PM; Struijk DG; Tjandra YI; ter Wee PM; de Charro FT
Nephrol Dial Transplant; 2003 Feb; 18(2):390-6. PubMed ID: 12543897
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score.
Chang YT; Hwang JS; Hung SY; Tsai MS; Wu JL; Sung JM; Wang JD
Sci Rep; 2016 Jul; 6():30266. PubMed ID: 27461186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
